Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL)

Matthew Davids, MD Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses current treatments for chronic lymphocytic leukemia (CLL) and the exciting possibilities for the future using immunotherapies. Dr. Davids shares how the goal of treatment is long term remission and quality of life. Since 2010, BTK Inhibitors, CAR T-cell therapy and other treatments have come on the market and have increased the possibilities for patients to live a long life with CLL. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Chronic Lymphocyctic Leukemia (CLL)How CAR T Cell Therapy Gives Hope to Cancer Patients Podcast EpisodeCURE Magazine Article on CAR T and Young CLL PatientsAmerican Journal of Managed Care – CAR T cells persistMinimal/Measurable Residual Disease (MRD) Fact SheetCAR T-cell TherapyCAR T-Cell Therapy WebinarHow CAR T-Cell Therapy Works In Augmented RealityStem Cell TransplantAllogeneic Stem Cell TransplantAutologous Stem Cell TransplantLLS COVID-19 ResourcesClinical Trial Support CenterThe Bloodline Subscriber Lounge Additional LLS Support Resources:  Information SpecialistsFinancial supportFree telephone/web patient programs Patti Robinson Kaufmann First Connection ProgramFree booklets Online chats Caregiver support Support groups Free Nutrition Consultations LLS AdvocacySurvivorship Workbook Support for this episode provided by BeiGene USA, Inc.; Bristol Myers Squibb; Genentech, Inc. & Biogen; Loxo Oncology at Lilly and Pharmacyclics, An AbbVie Company & Janssen Biotech, and Thomas D. Oxley Fund for CLL Patient Education and Support.The post Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with Blood Cancer United Podcast.